Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition.

The Proceedings of the Nutrition Society - 1 Aug 2016

McAuley E, McNulty H, Hughes C, Strain J J, Ward M

Abstract excerpt

Clinical deficiency of the B-vitamin riboflavin (vitamin B2) is largely confined to developing countries; however accumulating evidence indicates that suboptimal riboflavin status is a widespread problem across the developed world. Few international data are available on riboflavin status as measured by the functional biomarker, erythrocyte glutathione reductase activation coefficient, considered to be the gold...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Supplements
Share to Folic Acid
Share to Ireland

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Nutritional Requirements

Share to Nutritional Status

Share to Randomized Controlled Trials as Topic

Share to Riboflavin

Source

Identifiers

PMID: 27170501
DOI: 10.1017/S0029665116000197

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition.PMID 27170501Read ↗

Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension.Semantic proximity Read ↗

Effect of riboflavin supplementation on blood pressure and possible effect modification by the MTHFR C677T polymorphism: a randomised trial in rural GambiaSemantic proximity Read ↗

Impact of the common MTHFR 677C→T polymorphism on blood pressure in adulthood and role of riboflavin in modifying the genetic risk of hypertension: evidence from the JINGO project.Semantic proximity Read ↗

Impact of the MTHFR C677T polymorphism on blood pressure and related central haemodynamic parameters in healthy adults.Semantic proximity Read ↗

B-vitamins, methylenetetrahydrofolate reductase (MTHFR) and hypertension.Semantic proximity Read ↗

DNA methylation of hypertension-related genes and effect of riboflavin supplementation in adults stratified by genotype for the MTHFR C677T polymorphism.Semantic proximity Read ↗

Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years.Semantic proximity Read ↗

Evidence of a Role for One-Carbon Metabolism in Blood Pressure: Can B Vitamin Intervention Address the Genetic Risk of Hypertension Owing to a Common Folate Polymorphism?Semantic proximity Read ↗

Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.Semantic proximity Read ↗

Postgraduate Symposium: The MTHFR C677T polymorphism, B-vitamins and blood pressure.Semantic proximity Read ↗

Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial.Semantic proximity Read ↗

Anaemia during pregnancy: could riboflavin deficiency be implicated?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.